English | Español
Patient Daily | Mar 4, 2026

CDC’s principal deputy director Ralph Abraham resigns amid leadership changes
Patient Daily | Mar 4, 2026

Merck restructures human health division ahead of Keytruda patent expiration
Patient Daily | Mar 4, 2026

Vanda receives FDA approval for new antipsychotic after previous setback
Patient Daily | Mar 4, 2026

FDA proposes regulatory path for individualized gene editing therapies targeting rare diseases
Patient Daily | Mar 4, 2026

Novo Nordisk’s obesity drug fails key test against Eli Lilly rival
Patient Daily | Mar 4, 2026

Appellate court rules for REGENXBIO over Sarepta in gene therapy patent case
Patient Daily | Mar 4, 2026

Congress approves record $315 million for ALS research amid new treatment efforts
Patient Daily | Mar 4, 2026

Gene therapies for sickle cell disease face slow uptake despite early promise

Trending
Patient Daily | Feb 25, 2026

Legal reporter: GOP has figured out ‘big money is getting in bed with mass tort lawyers’
+ Pharmaceuticals
Patient Daily | Feb 25, 2026

Dallas Breathe Free announces high patient satisfaction in sinus and allergy care
+ Regulatory
Patient Daily | Feb 25, 2026

BlackDoctor.org calls for reforms to federal 340B drug pricing program
+ Pharmaceuticals
Patient Daily | Feb 26, 2026

FDA shifts stance on drug approvals with move toward single pivotal trial